S'abonner

Global prevalence of antibiotic consumption during pregnancy: A systematic review and meta-analysis - 16/07/24

Doi : 10.1016/j.jinf.2024.106189 
Sheila A. Orwa a, Unnur Gudnadottir b, Annelies Boven a, b, c, Ines Pauwels c, Ann Versporten c, Erika Vlieghe a, c, d, Nele Brusselaers a, e,
a Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium 
b Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden 
c Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium 
d General Internal Medicine, Infectious Diseases and Tropical Medicine, Antwerp University Hospital, Antwerp, Belgium 
e Department of Public Health and Primary Care, Ghent University, Ghent, Belgium 

Correspondence to: Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden.Department of Women’s and Children’s Health, Karolinska InstitutetStockholmSweden

Summary

Background

Antibiotic use during pregnancy is widespread with notable variations across regions.

Methods

This systematic review and meta-analysis (Prospero protocol CRD42023418979) examines the prevalence and variability of antibiotic use in pregnancy globally and regionally, considering different methodologies and maternal characteristics. We searched Embase, PubMed, and Web of Science for observational studies published in English from the year 2000 and onwards. Random-effect meta-analyses were used to pool the prevalence of antibiotic consumption during pregnancy, presented as percentages with 95% confidence intervals (CI). Joanna Briggs Institute Critical appraisal checklist for prevalence studies was used for bias assessment.

Findings

Overall, 116 studies (14 from Africa, 24 from the Americas, six from Eastern Mediterranean, 57 from Europe, four from South-East Asia and 11 from Western Pacific) were included (33,821,194 pregnancies). The majority of studies (84.5%) were appraised with a low risk of bias. The prevalence of antibiotic consumption during pregnancy ranged between 0.04 to 90%, with a pooled estimate of 23.6% (95% CI: 20.1–27.5, I2 =100%). Low-income countries had the highest pooled prevalence (45.3%, 95% CI: 15.4–79.1, I2 =99.6%). Regionally, the Western Pacific had the highest pooled prevalence (34.4%, 95% CI: 13.4–64.1, I2 =100%). The prevalence of antibiotic consumption during pregnancy increased over time in the Americas and Western Pacific. The studies exhibited considerable heterogeneity (I2 >95%), and the trim-and-fill method estimated a potential 10% underestimation of the overall pooled prevalence, suggesting publication bias.

Interpretation

This meta-analysis suggests that about 1/4 of women worldwide use antibiotics during pregnancy. This study suggests a high prevalence of antibiotic consumption during pregnancy with disparities according to region and level of country income, ethnicity and whether antibiotics were prescribed or self-medicated. There was a variability in reported findings across age categories, potential bias from small sample sizes, and language bias from including only studies published in English.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




ga1

Le texte complet de cet article est disponible en PDF.

Highlights

This is the first comprehensive global analysis of antibiotic use during pregnancy.
Antibiotic consumption during pregnancy is prevalent worldwide with important variations
The Western Pacific region exhibited highest prevalence rates compared to other regions.
Ethnicity, pregnancy trimester and the economic level also seemed to influence prevalence.
Approximately one in four individuals consumed antibiotics during pregnancy

Le texte complet de cet article est disponible en PDF.

Keywords : Pregnancy, Antibiotics, Real world evidence, Drug utilization, Meta-analysis, Pre-natal


Plan


© 2024  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 89 - N° 2

Article 106189- août 2024 Retour au numéro
Article précédent Article précédent
  • Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis
  • Juan Jiang, Yantong Li, Qiaoling Jiang, Yu Jiang, Hongqian Qin, Yuanyuan Li
| Article suivant Article suivant
  • Elderly patients with tuberculosis in a low-incidence country – Clinical characteristics, inflammation and outcome
  • Cynthia van Arkel, Iris Storms, Lisa Kurver, Frank Smeenk, Pascal Wielders, Wouter Hoefsloot, Neeltje Carpaij, Martin J. Boeree, Reinout van Crevel, Arjan van Laarhoven, Cécile Magis-Escurra

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.